These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36523268)

  • 1. Polygenic coronary artery disease association with brain atrophy in the cognitively impaired.
    de Silva E; Sudre CH; Barnes J; Scelsi MA; Altmann A;
    Brain Commun; 2022; 4(6):fcac314. PubMed ID: 36523268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults.
    Soldan A; Wang J; Pettigrew C; Davatzikos C; Erus G; Hohman TJ; Dumitrescu L; Bilgel M; Resnick SM; Rivera-Rivera LA; Langhough R; Johnson SC; Benzinger T; Morris JC; Laws SM; Fripp J; Masters CL; Albert MS
    Brain Commun; 2024; 6(5):fcae276. PubMed ID: 39229494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presumed small vessel disease, imaging and cognition markers in the Alzheimer's Disease Neuroimaging Initiative.
    Fiford CM; Sudre CH; Young AL; Macdougall A; Nicholas J; Manning EN; Malone IB; Walsh P; Goodkin O; Pemberton HG; Barkhof F; Alexander DC; Cardoso MJ; Biessels GJ; Barnes J;
    Brain Commun; 2021; 3(4):fcab226. PubMed ID: 34661106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular and Alzheimer's disease biomarkers in dementia with Lewy bodies and other dementias.
    Rennie A; Ekman U; Shams S; Rydén L; Samuelsson J; Zettergren A; Kern S; Oppedal K; Blanc F; Hort J; Garcia-Ptacek S; Antonini A; Lemstra AW; Padovani A; Kramberger MG; Rektorová I; Walker Z; Snædal J; Pardini M; Taylor JP; Bonanni L; Granberg T; Aarsland D; Skoog I; Wahlund LO; Kivipelto M; Westman E; Ferreira D
    Brain Commun; 2024; 6(5):fcae290. PubMed ID: 39291165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive analysis of methods for assessing polygenic burden on Alzheimer's disease pathology and risk beyond
    Altmann A; Scelsi MA; Shoai M; de Silva E; Aksman LM; Cash DM; Hardy J; Schott JM
    Brain Commun; 2020; 2(1):fcz047. PubMed ID: 32226939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular disease promotes tau pathology in Alzheimer's disease.
    Laing KK; Simoes S; Baena-Caldas GP; Lao PJ; Kothiya M; Igwe KC; Chesebro AG; Houck AL; Pedraza L; Hernández AI; Li J; Zimmerman ME; Luchsinger JA; Barone FC; Moreno H; Brickman AM;
    Brain Commun; 2020; 2(2):fcaa132. PubMed ID: 33215083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes.
    Manzali SB; Yu E; Ravona-Springer R; Livny A; Golan S; Ouyang Y; Lesman-Segev O; Liu L; Ganmore I; Alkelai A; Gan-Or Z; Lin HM; Heymann A; Schnaider Beeri M; Greenbaum L
    Front Aging Neurosci; 2022; 14():853695. PubMed ID: 36110429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensities and patterns of atrophy in early onset Alzheimer's disease with causative gene mutations.
    Mao C; Li J; Huang X; Dong L; Liu C; Peng B; Cui L; Gao J
    Clin Neurol Neurosurg; 2021 Apr; 203():106552. PubMed ID: 33601235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
    Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
    Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
    Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
    Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease.
    Daunt P; Ballard CG; Creese B; Davidson G; Hardy J; Oshota O; Pither RJ; Gibson AM
    J Prev Alzheimers Dis; 2021; 8(1):78-83. PubMed ID: 33336228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.
    Fiford CM; Manning EN; Bartlett JW; Cash DM; Malone IB; Ridgway GR; Lehmann M; Leung KK; Sudre CH; Ourselin S; Biessels GJ; Carmichael OT; Fox NC; Cardoso MJ; Barnes J;
    Hippocampus; 2017 Mar; 27(3):249-262. PubMed ID: 27933676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.
    Tan CH; Bonham LW; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Yokoyama JS; Rabinovici GD; Miller BL; Yaffe K; Schellenberg GD; Kauppi K; Holland D; McEvoy LK; Kukull WA; Tosun D; Weiner MW; Sperling RA; Bennett DA; Hyman BT; Andreassen OA; Dale AM; Desikan RS;
    Brain; 2019 Feb; 142(2):460-470. PubMed ID: 30689776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considering the APOE locus in Alzheimer's disease polygenic scores in the Health and Retirement Study: a longitudinal panel study.
    Ware EB; Faul JD; Mitchell CM; Bakulski KM
    BMC Med Genomics; 2020 Nov; 13(1):164. PubMed ID: 33143703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.